Exagamglogene Autotemcel Meets End Points in Severe Sickle Cell Disease, β-Thalassemia
Two posters set to be presented at the 65th American Society of Hematology Annual Meeting & Exposition met their primary and secondary end points regarding exagamglogene autotemcel therapy for sickle cell disease and β-thalassemia.
United States American Society Of Hematology American Society Annual Meeting Cell Anemia Ezume Images
Source: ajmc.com